YuanSheng Ventures

YuanSheng Ventures (元生资本) is a Chinese venture capital fund that has led or co-led several growth-stage deals in the healthcare and consumer sectors. In March 2021, it led the $50 million Series B for aromatherapy skincare brand Zhuben, following its Series A lead in the same round structure . That same year, in July 2021, it led the tens-of-millions-of-dollars Series A+ for neoX Biotech, a computational drug-discovery company, bringing that firm's total raised to nearly $100 million . More recently, in August 2025, YuanSheng co-led a $41 million founding round for Aikelian Biotechnology alongside Sequoia China and Xingze Capital, with 5Y Capital also participating . The fund's activity clusters in biotech and consumer brands, typically entering at Series A or B stage.